IQV
$166.07-0.40 (-0.24%)
IQVIA Holdings Inc.
Recent News
3 Value Stocks We Steer Clear Of
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
3 Mid-Cap Stocks We Keep Off Our Radar
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.
1 S&P 500 Stock Worth Your Attention and 2 We Question
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.
IQVIA Expands In Vitro Discovery Footprint As Shares Face Pressure
IQVIA Holdings (NYSE:IQV) has agreed to acquire discovery services assets from Charles River Laboratories. The deal adds in vitro discovery capabilities across five additional sites to IQVIA's existing network. The transaction is aimed at expanding IQVIA's role in early stage drug discovery services and related data offerings. IQVIA Holdings, trading at $170.93, has had a mixed share price record recently, with a 7 day return of a 1.7% decline and a 30 day return of an 8.8% decline. Over...
IQVIA Holdings Inc. (IQV) Advances Clinical Research and Data Capabilities to Drive Growth
IQVIA Holdings Inc. (NYSE:IQV) is one of the 11 Best Affordable Growth Stocks to Buy Now. On March 3, analysts at RBC Capital initiated coverage of IQVIA Holdings Inc. (NYSE:IQV) with an Outperform rating and a $221 price target. According to RBC Capital analyst Ryan Halsted, the company is making significant progress in clinical trial […]